Table 2 Efficacy summary (n = 94)
No. (%) | ORR (%) | mTTP (months) (95Â % CI) | mOS (months) (95Â % CI) |
|---|---|---|---|
Arm A (no ESOM) (n = 32) | 46.9 | 8.7 (6.8-10.6) | 19.2 (10.1-28.3) |
Arm B (lower dose ESOM (n = 31) | 71.0 | 9.4 (5.8-13.1) | 39.3 (31.6-47.1) |
Arm C (higher dose ESOM (n = 31) | 64.5 | 9.7 (7.8-11.6) | 26.1 (21.1-31.1) |
Arm B + C (Combined(n = 62) | 67.7 | 9.7 (7.6-11.8) | 29.9 (22.3-37.4) |